Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2015 Jul 6;2015(7):CD011777.
doi: 10.1002/14651858.CD011777.

Pharmacological interventions for self-harm in adults

Keith Hawton  1 , Katrina G Witt, Tatiana L Taylor Salisbury, Ella Arensman, David Gunnell, Philip Hazell, Ellen Townsend, Kees van Heeringen
Affiliations
Meta-Analysis

Pharmacological interventions for self-harm in adults

Keith Hawton et al. Cochrane Database Syst Rev. .

Abstract

Background: Self-harm (SH; intentional self-poisoning or self-injury) is common, often repeated, and strongly associated with suicide. This is an update of a broader Cochrane review on psychosocial and pharmacological treatments for deliberate SH, first published in 1998 and previously updated in 1999. We have now divided the review into three separate reviews. This review is focused on pharmacological interventions in adults who self harm.

Objectives: To identify all randomised controlled trials of pharmacological agents or natural products for SH in adults, and to conduct meta-analyses (where possible) to compare the effects of specific treatments with comparison types of treatment (e.g., placebo/alternative pharmacological treatment) for SH patients.

Search methods: For this update the Cochrane Depression, Anxiety and Neurosis Review Group (CCDAN) Trials Search Co-ordinator searched the CCDAN Specialised Register (September 2014). Additional searches of MEDLINE, EMBASE, PsycINFO, and CENTRAL were conducted to October 2013.

Selection criteria: We included randomised controlled trials comparing pharmacological treatments or natural products with placebo/alternative pharmacological treatment in individuals with a recent (within six months) episode of SH resulting in presentation to clinical services.

Data collection and analysis: We independently selected trials, extracted data, and appraised trial quality. For binary outcomes, we calculated odds ratios (ORs) and their 95% confidence intervals (CIs). For continuous outcomes we calculated the mean difference (MD) and 95% CI. Meta-analysis was only possible for one intervention (i.e. newer generation antidepressants) on repetition of SH at last follow-up. For this analysis, we pooled data using a random-effects model. The overall quality of evidence for the primary outcome was appraised for each intervention using the GRADE approach.

Main results: We included seven trials with a total of 546 patients. The largest trial included 167 participants. We found no significant treatment effect on repetition of SH for newer generation antidepressants (n = 243; k = 3; OR 0.76, 95% CI 0.42 to 1.36; GRADE: low quality of evidence), low-dose fluphenazine (n = 53; k = 1; OR 1.51, 95% CI 0.50 to 4.58; GRADE: very low quality of evidence), mood stabilisers (n = 167; k = 1; OR 0.99, 95% CI 0.33 to 2.95; GRADE: low quality of evidence), or natural products (n = 49; k = 1; OR 1.33, 95% CI 0.38 to 4.62; GRADE: low quality of evidence). A significant reduction in SH repetition was found in a single trial of the antipsychotic flupenthixol (n = 30; k = 1; OR 0.09, 95% CI 0.02 to 0.50), although the quality of evidence for this trial, according to the GRADE criteria, was very low. No data on adverse effects, other than the planned outcomes relating to suicidal behaviour, were reported.

Authors' conclusions: Given the low or very low quality of the available evidence, and the small number of trials identified, it is not possible to make firm conclusions regarding pharmacological interventions in SH patients. More and larger trials of pharmacotherapy are required. In view of an indication of positive benefit for flupenthixol in an early small trial of low quality, these might include evaluation of newer atypical antipsychotics. Further work should include evaluation of adverse effects of pharmacological agents. Other research could include evaluation of combined pharmacotherapy and psychological treatment.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1
1
Search flow diagram of included and excluded trials.
2
2
Risk of bias graph: Review authors' judgements for each risk of bias item presented as percentages across all included trials.
3
3
Risk of bias summary graph: review authors' judgements about each risk of bias item for each included trial.
1.1
1.1. Analysis
Comparison 1: Newer generation antidepressants versus placebo, Outcome 1: Repetition of SH at last follow‐up
1.2
1.2. Analysis
Comparison 1: Newer generation antidepressants versus placebo, Outcome 2: Repetition of SH at last follow‐up (by NGA drug)
See this image and copyright information in PMC

References

References to studies included in this review

Battaglia 1999 {published data only}
    1. Battaglia J, Wolff TK, Wagner-Johnson DS, Rush AJ, Carmody TJ, Basco MR. Structured diagnostic assessment and depot fluphenazine treatment of multiple suicide attempters in the emergency department. International Clinical Psychopharmacology 1999;14:361-72. - PubMed
Hallahan 2007 {published data only}
    1. Hallahan B, Hibbeln RJ, Davis JM, Garland MR. Omega-3 fatty acid supplementation in patients with recurrent self-harm: Single-centre double-blind randomised controlled trial. The British Journal of Psychiatry 2007;190:118-22. - PubMed
Hirsch 1982 {published and unpublished data}
    1. Draper R, Hirsch SR. Treatment of parasuicide patients with mianserin, nomifensine and placebo: A double blind placebo controlled trial. Unpublished manuscript 1982.
    1. Hirsch S, Walsh C, Draper R. Parasuicide: A review of treatment interventions. Journal of Affective Disorders 1982;4:299-311. - PubMed
Lauterbach 2008 {published and unpublished data}
    1. Lauterbach E, Ahrens B, Felber W, Muller-Oerlinghausen B, Kilb B, Bischof G, et al. Suicide prevention by lithium (SUPLI): Challenges of a multi-center prospective study. Archives of Suicide Research 2005;9:27-34. - PubMed
    1. Lauterbach E, Felber W, Müller-Oerlinghausen B, Ahrens B, Bronisch T, Meyer T, et al. Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: A randomised, placebo-controlled, 1-year trial. Acta Psychiatrica Scandinavica 2008;118:469-79. - PubMed
Montgomery 1979 {published data only}
    1. Montgomery S, Montgomery D, Jayanthi-Rani S, Roy D, Shaw P, McAuley R. Maintenance therapy in repeat suicidal behaviour: A placebo controlled trial. In: Proceedings of the 10th International Congress for Suicide Prevention and Crisis Intervention. Ottawa, Canada, 1979:227-9.
Montgomery 1983 {published data only}
    1. Montgomery S, Roy D, Montgomery D. The prevention of recurrent suicidal acts. British Journal of Clinical Pharmacology 1983;15:183s-8s. - PMC - PubMed
Verkes 1998 {published data only}
    1. Verkes RJ, Mast RC, Hengeveld MW, Tuyl JP, Zwinderman AH, Kempen GMJ. Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression. American Journal of Psychiatry 1998;155:543-7. - PubMed

References to studies excluded from this review

Ciprani 2013 {published data only}
    1. Cipriani A, Girlanda F, Agrimi E, Barichello A, Beneduce R, Bighelli I, et al. Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: A protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial. BMC Psychiatry 2013;13:212. - PMC - PubMed
Gibbons 2012 {published data only}
    1. Gibbons RD, Brown H, Hur K, Davis JM, Mann JJ. Suicidal thoughts and behavior with antidepressant treatment: Reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Archives of General Psychiatry 2012;69:580-7. - PMC - PubMed
Kelip 2010 {published data only}
    1. Kelip JG, Oquendo MA, Stanley BH, Burke AK, Cooper TB, Malone KM, et al. Future suicide attempt and responses to serotonergic challenge. Neuropsychopharmacology 2010;35:1063-72. - PMC - PubMed
Meltzer 2003 {published data only}
    1. Meltzer HY, Alphs L, Green AI, Altamura C, Anard R, Bertoldi A, et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Archives of General Psychiatry 2003;60:82-91. - PubMed
    1. Meltzer HY. Reducing risk of suicide in schizophrenia. European Neuropsychopharmacology 2003;13:s163.
    1. Potkin SG, Alphs L, Hsu C, Krishnan RR, Anand R, Young FK, et al. Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial. Biological Psychiatry 2003;54:444-52. - PubMed
Nickel 2006 {published data only}
    1. Nickel MK, Muehlbacher M, Nickel C, Kettler C, Gil FP, Bachler E, et al. Aripiprazole in the treatment of patients with borderline personality disorder: A double-blind, placebo-controlled study. The American Journal of Psychiatry 2006;163:833-8. - PubMed
Oquendo 2011 {published data only}
    1. Oquendo MA, Galfalvy HC, Currier D, Grunebaum MF, Sher L, Sullivan GM, et al. Treatment of suicide attempters with bipolar disorder: A randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior. American Journal of Psychiatry 2011;168:1050–6. - PMC - PubMed
Pompili 2012 {published data only}
    1. Pompili M, Rihmer Z, Gonda X, Serafini G, Sher L, Girardi P. Early onset of action and sleep-improving effect are crucial in decreasing suicide risk: The role of quetiapine XR in the treatment of unipolar and bipolar depression. Rivista di Psichiatria 2012;47:489-97. - PubMed
Price 2014 {published data only}
    1. Price RB, Iosifescu DV, Murrough JW, Chang LC, Al Jurdi RK, Iqbal SZ, et al. Effects of ketamine on explicit and implicit suicidal cognition: A randomized controlled trial in treatment-resistant depression. Depression and Anxiety 2014;31:335-3. - PMC - PubMed
Reeves 2008 {published data only}
    1. Reeves H, Batra S, May RS, Zhang R, Dahl DC, Li X. Efficacy of risperidone augmentation to antidepressants in the management of suicidality in major depressive disorder: A randomized, double-blind, placebo-controlled pilot study. Journal of Clinical Psychiatry 2008;69:1228-36. - PubMed
Roth 2012 {published data only}
    1. Roth TL, Mahoney EM, Dundon WD, Pettinati HM. Combination pharmacotherapy sertraline and naltrexone decreases suicidal ideation scores in co-morbid depressed alcoholics. Alcoholism: Clinical and Experimental Research 2012;36:245A.
Rucci 2011 {published data only}
    1. Rucci P, Frank E, Scocco P, Calugi S, Miniati M, Fagiolini A, et al. Treatment-emergent suicidal ideation during 4 months of acute management of unipolar major depression with SSRI pharmacotherapy or interpersonal psychotherapy in a randomized clinical trial. Depression and Anxiety 2011;28:303-9. - PMC - PubMed
Sandman 2008 {published data only}
    1. Sandman CA, Touchette PE, Marion SD, Chicz-DeMet A. The role of proopiomelanocortin (POMC) in sequentially dependent self-injurious behavior. Developmental Psychobiology 2008;7:680-9. - PMC - PubMed

References to ongoing studies

Liang 2014 {published and unpublished data}
    1. NCT01928446. CSP #590 - Lithium for Suicidal Behavior in Mood Disorders. https://clinicaltrials.gov/ct2/show/NCT01928446 2013 (accessed 26-June-2015).
Sharon 2014 {published and unpublished data}
    1. NCT02037503. Effect of Oral Ketamine Treatment on Suicidal Ideation and Drug Resistant Major Depression, a Clinical and fMRI Study. https://clinicaltrials.gov/ct2/show/NCT02037503 2014 (accessed 26-June-2015).

Additional references

Ahmadi 2007
    1. Ahmadi A. Suicide by self-immolation: Comprehensive overview, experiences and suggestions. Journal of Burns Care Research 2007;28:30-41. - PubMed
Albrecht 2014
    1. Albrecht B, Staiger PK, Hall K, Miller P, Best D, Lubman DI. Benzodiazepine use and aggressive behaviour: A systematic review. Australian and New Zealand Jounral of Psychiatry 2014;48:1096-114. - PubMed
American Psychiatric Association 2013
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition (DSM-5). Arlington, VA: American Psychiatric Association, 2013.
Baldessarini 2003
    1. Baldessarini RJ, Tondo L, Hennen J. Lithium treatment and suicide risk in major affective disorders: Update and new findings. Journal of Clinical Psychiatry 2003;64:s44-52. - PubMed
Baldessarini 2006
    1. Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J. Decreased risk of suicides and attempts during long-term lithium treatment: A meta-analytic review. Bipolar Disorders 2006;8:625-39. - PubMed
Beasley 1991
    1. Beasley CM, Dornseif BE, Bosomworth JC, Sayler ME, Rampey Jr AH, Heiligenstein JH, et al. Fluoxetine and suicide: A meta-analysis of controlled trials of treatment for depression. British Medical Journal 1991;303:685-92. - PMC - PubMed
Beck 1961
    1. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 1961;4:561. - PubMed
Beck 1974
    1. Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: the Hopelessness Scale. Journal of Consulting and Clinical Psychology 1974;42:861-5. - PubMed
Beck 1988
    1. Beck AT, Steer RA, Ranieri WF. Scale for Suicide Ideation: Psychometric properties of a self-report version. Journal of Clinical Psychology 1988;44:499-505. - PubMed
Borges 2011
    1. Borges G, Nock MK, Abad JMH, Hwang I, Sampson NA, Alonso J, et al. Twelve month prevalence of and risk factors for suicide attempts in the WHO World Mental Health Surveys. Journal of Clinical Psychiatry 2010;71(12):1617-1628. - PMC - PubMed
Boyce 2003
    1. Boyce P, Carter G, Penrose-Wall J, Wilhelm K, Goldney R. Summary Australian and New Zealand clinical practice guideline for the management of adult deliberate self-harm (2003). Australasian Psychiatry 2003;11:150-5.
Brausch 2012
    1. Brausch AM, Girresch SK. A review of empirical treatment studies for adolescent nonsuicidal self-injury. Journal of Cognitive Psychotherapy: An International Quarterly 2012;26:3-18.
Brunner 2002
    1. Brunner J, Parhofer KG, Schwandt P, Bronisch T. Cholesterol, essential fatty acids, and suicide. Pharmacopsychiatry 2002;35:1-5. - PubMed
Burns 2000
    1. Burns JM, Patton GC. Preventive interventions for youth suicide: A risk factor-based approach. Australian and New Zealand Journal of Psychiatry 2000;34:388-407. - PubMed
Carroll 2014
    1. Carroll R, Metcalfe C, Gunnell D. Hospital presenting self-harm and risk of fatal and non-fatal repetition: Systematic review and meta-analysis. PLoS One 2014;9:e89944. - PMC - PubMed
Christensen 2014
    1. Christensen H, Calear AL, Spijker B, Gosling J, Petrie K, Donker T, et al. Psychosocial interventions for suicidal ideation, plans, and attempts: A database of randomised controlled trials. BMC Psychiatry 2014;14:86. - PMC - PubMed
Cipriani 2005
    1. Cipriani A, Pretty H, Hawton K, Geddes JR. Lithium in the prevention of suicide behavior and all-cause mortality in patients with mood disorders: A systematic review of randomized trials. American Journal of Psychiatry 2005;162:1805-19. - PubMed
Cipriani 2013a
    1. Cipriani A, Hawton K, Stockton S, Geddes JR. Lithium in the prevention of suicide in mood disorders: Updated systematic review and meta-analysis. British Medical Journal 2013;346:f3646. - PubMed
Cipriani 2013b
    1. Cipriani A, Reid K, Young AH, Macritchie K, Geddes J. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database of Systematic Reviews 2013;10:CD003196. - PMC - PubMed
Claassen 2006
    1. Claassen CA, Trivedi MH, Shimizu I, Stewart S, Larkin GL, Litovitz T. Epidemiology of nonfatal deliberate self-harm in the United States as described in three medical databases. Suicide and Life-Threatening Behavior 2006;36:192-212. - PubMed
Comtois 2006
    1. Comtois KA, Linehan MM. Psychosocial treatments of suicidal behaviors: A practice-friendly review. Journal of Clinical Psychology in Session 2006;62:161-70. - PubMed
Cooper 2005
    1. Cooper J, Kapur N, Webb R, Lawlor M, Guthrie E, Mackway-Jones K, et al. Suicide after deliberate self-harm: A 4-year cohort study. American Journal of Psychiatry 2005;162:297-303. - PubMed
Crawford 2007a
    1. Crawford MJ, Thomas O, Khan N, Kulinskaya E. Psychosocial interventions following self-harm: Systematic review of their efficacy in preventing suicide. British Journal of Psychiatry 2007;190:11-7. - PubMed
Crawford 2007b
    1. Crawford MJ, Kumar P. Intervention following deliberate self-harm: Enough evidence to act? Evidence-Based Mental Health 2007;10:37-9. - PubMed
Curtin 2002a
    1. Curtin F, Elbourne D, Altman DG. Meta-analysis combining parallel and cross-over clinical trials. III: The issue of carry-over. Statistics in Medicine 2002;21:2161-73. - PubMed
Curtin 2002b
    1. Curtin F, Altman DG, Elbourne D. Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes. Statistics in Medicine 2002;21:2131-44. - PubMed
Daigle 2011
    1. Daigle MS, Pouliot L, Chagnon F, Greenfield B, Mishara B. Suicide attempts: Prevention of repetition. Canadian Journal of Psychiatry 2011;56:621-9. - PubMed
Daniel 2009
    1. Daniel SS, Goldston DB. Interventions for suicidal youth: A review of the literature and developmental considerations. Suicide and Life-Threatening Behavior 2009;39:252-68. - PMC - PubMed
Deeks 2008
    1. Deeks JJ, Higgins JPT, Altman DG on behalf of the Cochrane Statistical Methods Group. Analysing data and undertaking analyses. In: Higgins JPT, Green S, editors(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester, UK: John Wiley & Sons, 2008.
Department of Health 2012
    1. Department of Health. Preventing suicide in England: A cross-government outcomes strategy to save lives. London: Her Majesty's Government/Department of Health, 2012.
Dew 1987
    1. Dew MA, Bromet EJ, Brent D. A quantitative literature review of the effectiveness of suicide prevention centers. Journal of Consulting and Clinical Psychology 1987;55:239-44. - PubMed
Donner 2002
    1. Donner A, Klar N. Issues in the meta-analysis of cluster randomized trials. Statistics in Medicine 2002;21:2971-80. - PubMed
Eddleston 2000
    1. Eddleston M. Patterns and problems of deliberate self-poisoning in the developing world. Quarterly Journal of Medicine: An International Journal of Medicine 2000;93:715-31. - PubMed
Egger 1997
    1. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 1997;315:629-34. - PMC - PubMed
Elbourne 2002
    1. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: Methodological issues. International Journal of Epidemiology 2002;31:140-9. - PubMed
Engles 2003
    1. Engles JM, Diehr P. Imputation of missing longitudinal data: A comparison of methods. Journal of Clinical Epidemiology 2003;56:968-76. - PubMed
Erez 1996
    1. Erez A, Bloom MC, Wells MT. Using random rather than fixed effects models in meta-analysis: Implications for situation specificity and validity generalization. Personnel Psychology 1996;49:275-306.
Feighner 1999
    1. Feighner JP. Mechanism of action of antidepressant medications. Journal of Clinical Psychiatry 1999;60:s4-11. - PubMed
Fleischmann 2005
    1. Fleischmann A, Bertolote JM, Leo D, Botega N, Phillips M, Sisask M, et al. Characteristics of attempted suicides seen in emergency-care settings of general hospitals in eight low- and middle-income countries. Psychological Medicine 2005;35:1467-74. - PubMed
Fleiss 1994
    1. Fleiss JL. Measures of effect size for categorical data. In: Cooper H & Hedges LV, editors(s). The Handbook of Research Synthesis. New York, NY: Russell Sage Foundation, 1994:245-60.
Fond 2014
    1. Fond G, Loundou A, Rabu C, MacGregor A, Lançon C, Brittner M, et al. Ketamine administration in depressive disorders: A systematic review and meta-analysis. Psychopharmacology 2014;231:3663-76. - PubMed
Foster 1997
    1. Foster T, Gillespie K, McClelland R. Mental disorders and suicide in Northern Ireland. British Journal of Psychiatry 1997;170:447-52. - PubMed
Gairin 2003
    1. Gairin I, House A, Owens D. Attendance at the accident and emergency department in the year before suicide: Retrospective study. British Journal of Psychiatry 2003;183:28-33. - PubMed
Geddes 2004
    1. Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM. Long-term lithium therapy for bipolar disorder: Systematic review and meta-analysis of randomized controlled trials. American Journal of Psychiatry 2003;161:217-22. - PubMed
Gibbs 2004
    1. Gibbs S, Beautrais A. Epidemiology of attempted suicide in Canterbury Province, New Zealand (1993-2002). New Zealand Medical Journal 2004;117:U1141. - PubMed
Gjelsvik 2012
    1. Gjelsvik B, Heyerdahl F, Hawton K. Prescribed medication availability and deliberate self-poisoning: A longitudinal study. Journal of Clinical Psychiatry 2012;73:e548-54. - PubMed
Gould 2003
    1. Gould MS, Greenberg T, Velting DM, Shaffer D. Youth suicide risk and preventive interventions: A review of the past 10 years. Journal of the American Academy of Child and Adolescent Psychiatry 2003;42:386-405. - PubMed
GRADEpro [Computer program]
    1. GRADEpro. Cochrane Informatics and Knowledge Management Department, Accessed 24 September, 2014.
Gray 2001
    1. Gray SM, Otto MW. Psychosocial approaches to suicide prevention: Applications to patients with bipolar disorder. Journal of Clinical Psychiatry 2001;62:s56-64. - PubMed
Gunnell 1994
    1. Gunnell D, Frankel S. Prevention of suicide: Aspirations and evidence. British Medical Journal 1994;308:1227-33. - PMC - PubMed
Gunnell 2003
    1. Gunnell D, Eddleston M. Suicide by intentional ingestion of pesticides:a continuing tragedy in developing countries. International Journal of Epidemiology 2003;32:902-9. - PMC - PubMed
Hamilton 1960
    1. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 1960;23:56-62. - PMC - PubMed
Haw 2001
    1. Haw C, Hawton K, Houston K, Townsend E. Psychiatric and personality disorders in deliberate self-harm patients. British Journal of Psychiatry 2001;178:48-54. - PubMed
Hawton 1988
    1. Hawton K, Fagg J. Suicide, and other causes of death, following attempted suicide. British Journal of Psychiatry 1988;152:359-66. - PubMed
Hawton 2003a
    1. Hawton K, Harriss L, Hall S, Simkin S, Bale E, Bond A. Deliberate self-harm in Oxford, 1990-2000: A time of change in patient characteristics. Psychological Medicine 2003;33:987-96. - PubMed
Hawton 2003b
    1. Hawton K, Zahl D, Weatherall R. Suicide following deliberate self-harm: Long-term follow-up of patients who presented to a general hospital. British Journal of Psychiatry 2003;182:537-42. - PubMed
Hawton 2007
    1. Hawton K, Bergen H, Casey D, Simkin S, Palmer B, Cooper J, et al. Self-harm in England: A tale of three cities. Multicentre study of self-harm. Social Psychiatry and Psychiatric Epidemiology 2007;42:513-21. - PubMed
Hawton 2008
    1. Hawton K, Harriss L. The changing gender ratio in occurrence of deliberate self-harm across the life-cycle. Crisis 2008;29:4-10. - PubMed
Hawton 2010
    1. Hawton K, Bergen H, Simkin H, Cooper K, Waters K, Gunnell D, et al. Toxicity of antidepressants: Rates of suicide relative to prescribing and non-fatal overdose. British Journal of Psychiatry 2010;196:354-8. - PMC - PubMed
Hawton 2012
    1. Hawton K, Saunders KEA, O'Connor R. Self-harm and suicide in adolescents. Lancet 2012;379:2373-82. - PubMed
Hawton 2013
    1. Hawton K, Saunders KEA, Topiwala A, Haw C. Psychiatric disorders in patients presenting to hospital following self-harm: A systematic review. Journal of Affective Disorders 2013;151:821-30. - PubMed
Hennen 2005
    1. Hennen J, Baldessarini RJ. Suicidal risk during treatment with clozapine: A meta-analysis. Schizophrenia Research 2005;73:139-45. - PubMed
Hepp 2004
    1. Hepp U, Wittman L, Schnyder U, Michel K. Psychological and psychosocial interventions after attempted suicide: An overview of treatment studies. Crisis 2004;25:108-17. - PubMed
Heppner 1988
    1. Heppner P. The Problem-Solving Inventory. Palo Alto, CA: Consulting Psychologist Press, 1988.
Higgins 2003
    1. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. British Medical Journal 2003;327:557-60. - PMC - PubMed
Higgins 2008a
    1. Higgins JPT, Deeks JJ, Altman DG on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Assessing risk of bias in included studies. In: Higgins JPT, Green S, editors(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester, UK: John Wiley & Sons, 2008.
Higgins 2008b
    1. Higgins JPT, Deeks JJ, Altman DG on behalf of the Cochrane Statistical Methods Group. Special topics in statistics. In: Higgins JPT, Green S, editors(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester, UK: John Wiley & Sons, 2008.
Higgins 2008c
    1. Higgins JPT, Deeks JJ. Selecting studies and collecting data. In: Higgins JPT, Green S, editors(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester, UK: John Wiley & Sons, 2008.
Hjelmeland 2002
    1. Hjelmeland H, Hawton K, Nordvik H, Bille-Brahe U, Leo D, Fekete S, et al. Why people engage in parasuicide: A cross-cultural study of intentions. Suicide and Life-Threatening Behavior 2002;32:380-93. - PubMed
Hollingworth 2010
    1. Hollingworth SA, Burgess PM, Whiteford HA. Affective and anxiety disorders: Prevalence, treatment and antidepressant medication use. Australian and New Zealand Journal of Psychiatry 2010;44:513-9. - PubMed
Hopewell 2009
    1. Hopewell S, Loudon K, Clarke MJ, Oxman AD, Dickersin K. Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No: MR000006. [DOI: 10.1002/14651858.MR000006.pub3] - DOI - PMC - PubMed
Ilyas 2012
    1. Ilyas S, Moncrieff J. Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010. British Journal of Psychiatry 2012;200:393-8. - PubMed
Kapur 2010
    1. Kapur N, Cooper J, Bennewith O, Gunnell D, Hawton K. Postcards, green cards and telephone calls: Therapeutic contact with individuals following self-harm. British Journal of Psychiatry 2010;197:5-7. - PubMed
Kapur 2013
    1. Kapur N, Cooper J, O'Connor RC, Hawton K. Non-suicidal self-injury v. attempted suicide: New diagnosis or false dichotomy? British Journal of Psychiatry 2013;202:326-8. - PubMed
Kerry 1998
    1. Kerry SM, Bland JM. Analysis of a trial randomised in clusters. British Medical Journal 1998;316:54. - PMC - PubMed
Kinyanda 2005
    1. Kinyanda E, Hjelmeland H, Musisi S. Psychological factors in deliberate self-harm as seen in an urban African population in Uganda: A case-control study. Suicide and Life-Threatening Behavior 2005;35:468-77. - PubMed
Kliem 2010
    1. Kliem S, Kröger C, Kosfelder J. Dialectical behavior therapy for borderline personality disorder: A meta-analysis using mixed-effects modeling. Journal of Consulting and Clinical Psychology 2010;78:936-51. - PubMed
Kreitman 1969
    1. Kreitman N, Philip AE, Greer S, Bagley CR. Parasuicide. British Journal of Psychiatry 1969;115:746-77. - PubMed
Larkin 2014
    1. Larkin C, di Blasi Z, Arensman E. Risk factors for repetition of self-harm: A systematic review of prospective hospital-based studies. PLoS One 2014;9:e84282. - PMC - PubMed
Lester 1994
    1. Lester D. The effectiveness of centres for the prevention of suicide [L'efficacité des centres de prévention du suicide]. Santé Mentale au Québec 1994;19:15-24. - PubMed
Lilley 2008
    1. Lilley R, Owens D, Horrocks J, House A, Noble R, Bergen H, et al. Hospital care and repetition following self-harm: Multicentre comparison of self-poisoning and self-injury. British Journal of Psychiatry 2008;192:440-5. - PubMed
Linehan 1991
    1. Linehan MM, Armstrong HE, Suarez A, Allmon D, Heard HL. Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Archives of General Psychiatry 1991;48:1060-4. - PubMed
Links 2003
    1. Links PS, Bergmans Y, Cook M. Psychotherapeutic interventions to prevent repeated suicidal behavior. Brief Treatment and Crisis Intervention 2003;3:445-64.
Lorillard 2011a
    1. Lorillard S, Schmitt L, Andreoli A. How to treat deliberate self-harm from clinical research to effective treatment choice? Part 1: An update on treatment efficacy among unselected patients referred to emergency room with deliberate self-harm [Comment traiter la tentative de suicide? 1 re partie: Efficacité des interventions psychosociales chez des patients suicidants à la sortie des urgences]. Annales Médico-Psychologiques 2011;169:211-28.
Lorillard 2011b
    1. Lorillard S, Schmitt L, Andreoli A. How to treat suicide attempt? Part 2: A review of treatments and the efficiency among borderline personality disorder patients [Comment traiter la tentative de suicide? Seconde partie: Une revue des traitements et de leur efficacité chez de patients borderline]. Annales Médico-Psychologiques 2011;169:229-36.
Luxton 2013
    1. Luxton DD, June JD, Comtois KA. Can postdischarge follow-up contacts prevent suicide and suicidal behavior? A review of the evidence. Crisis 2013;34:32-41. - PubMed
Mann 2005
    1. Mann JJ, Apter A, Bertolote J, Beautrais A, Currier D, Haas A, et al. Suicide prevention strategies: A systematic review. Journal of the American Medical Association 2005;294:2064-74. - PubMed
Mann 2013
    1. Mann JJ. The serotonergic system in mood disorders and suicidal behaviour. Philosophical Transactions of The Royal Society (B Biological Sciences) 2013;368:20120537. - PMC - PubMed
Marshall 2000
    1. Marshall M, Lockwood A, Bradley C, Adams C, Joy C, Fenton, M. Unpublished rating scales: A major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry 2000;176:249-52. - PubMed
McMain 2007
    1. McMain S. Effectiveness of psychosocial treatments on suicidality in personality disorders. Canadian Journal of Psychiatry 2007;52:s103-14. - PubMed
Milner 2015
    1. Milner AJ, Carter G, Pirkis J, Robinson J, Spittal MJ. Letters, green cards, telephone calls and postcards: Systematic and meta-analytic review of brief contact interventions for reducing self-harm, suicide attempts and suicide. British Journal of Psychiatry 2015;206:184-90. - PubMed
Moher 1998
    1. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998;352:609-13. - PubMed
Möller, 1992
    1. Möller H-J. Attempted suicide: Efficacy of different aftercare strategies. International Clinical Psychopharmacology 1992;6:s58-69. - PubMed
Möller 1989
    1. Möller HJ. Efficacy of different strategies of aftercare for patients who have attempted suicide. Journal of the Royal Society of Medicine 1989;82:643-7. - PMC - PubMed
Montgomery 1995
    1. Montgomery SA, Dunner DL, Dunbar GC. Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. European Neuropsychopharmacology 1995;5:5-13. - PubMed
Muehlenkamp 2006
    1. Muehlenkamp JJ. Empirically supported treatments and general therapy guidelines for non-suicidal self-injury. Journal of Mental Health Counseling 2006;28:166-85.
Müller‐Oerlinghausen 2005
    1. Müller-Oerlinghausen B, Felber W, Berghöfer A, Lauterbach E, Ahrens B. The impact of lithium long-term medication of suicidal behavior and mortality of bipolar patients. Archives of Suicide Research 2005;9:307-19. - PubMed
Murphy 2012
    1. Murphy E, Kapur N, Webb R, Purandare N, Hawton K, Bergen H, et al. Risk factors for repetition and suicide following self-harm in older adults: Multicentre cohort study. British Journal of Psychiatry 2012;200:399-404. - PubMed
NCCMH 2004
    1. National Collaborating Centre for Mental Health. Clinical Guideline 16. Self-harm: the short-term physical and psychological management and secondary prevention of self-harm in primary and secondary care. London: National Institute for Clinical Excellence, 2004.
Nock 2007
    1. Nock MK, Teper R, Hollander M. Psychological treatment of self-injury among adolescents. Journal of Clinical Psychology 2007;63:1081-9. - PubMed
Nock 2010
    1. Nock MK. Self-injury. Annual Review of Psychology 2010;6:339-63. - PubMed
Office of the Surgeon General (US) 2012
    1. Office of the Surgeon General (US) / National Action Alliance for Suicide Prevention (US). 2012 National Strategy for Suicide Prevention: Goals and Objects for Action. A report of the U.S. Surgeon General and of the National Action Alliance for Suicide Prevention. Washington, DC: US Department of Health and Human Services, 2012. - PubMed
Olfson 2009
    1. Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Archives of General Psychiatry 2009;66:848-56. - PubMed
Ougrin 2011
    1. Ougrin D, Latif S. Specific psychological treatment versus treatment as usual in adolescents with self-harm: Systematic review and meta-analysis. Crisis 2011;32:74-80. - PubMed
Ougrin 2015
    1. Ougrin D, Tranah T, Stahl D, Moran P, Asarnow JR. Therapeutic interventions for suicide attempts and self-harm in adolescents: Systematic review and meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry 2015;54:97-107. - PubMed
Owens 2002
    1. Owens D, Horrocks J, House A. Fatal and non-fatal repetition of self-harm. Systematic review. British Journal of Psychiatry 2002;181:193-9. - PubMed
Parkar 2006
    1. Parkar SR, Dawani V, Weiss MG. Clinical diagnostic and sociocultural dimensions of deliberate self-harm in Mumbai, India. Suicide and Life-Threatening Behavior 2006;36:223-38. - PubMed
Perry 2012
    1. Perry IJ, Corcoran P, Fitzgerald AP, Keeley HS, Reulbach U, Arensman E. The incidence and repetition of hospital-treated deliberate self harm: Findings from the world's first national registry. PLoS One 2012;7:e31663. - PMC - PubMed
Rana 2013
    1. Rana F, Gormez A, Varghese S. Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities. Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No: CD009084. [DOI: 10.1002/14651858.CD009084.pub2] - DOI - PMC - PubMed
Ross 2007
    1. Ross BM, Seguin J, Sieswerda LE. Omega-3 fatty acids as treatments for mental illness: Which disorder and which fatty acid? Lipids in Health and Disease 2007;6:21. - PMC - PubMed
Royal College of Psychiatrists 1994
    1. Royal College of Psychiatrists. The General Hospital Management of Adult Deliberate Self-Harm. Council Report CR32. London: Royal College of Psychiatrists, 1994.
Royal College of Psychiatrists 2004
    1. Royal College of Psychiatrists. Assessment Following Self-Harm in Adults. Council Report CR122. London: Royal College of Psychiatrists, 2004.
Sackett 1997
    1. Sackett D. The Cochrane Colloboration Handbook. Oxford: Oxford Univeersity Press, 1997.
Sakinofsky 2000
    1. Sakinofsky I. Repetition of suicidal behaviour. In: Hawton K, Heeringen K, editors(s). The International Handbook of Suicide and Attempted Suicide. Chichester: Wiley, 2000:385-404.
Schmidtke 1996
    1. Schmidtke A, Bille Brahe U, Leo D, Kerkhof A, Bjerke T, Crepet P, et al. Attempted suicide in Europe: Rates, trends and sociodemographic characteristics of suicide attempters during the period 1989-1992. Results of the WHO/EURO Multicentre Study on Parasuicide. Acta Psychiatrica Scandinavica 1996;93:327-38. - PubMed
Schmidtke 2004
    1. Schmidtke A, Weinacker B, Lähr C, Bille-Brahe U, Leo D, Kerkhof A, et al. Suicide and suicide attempts in Europe - An overview. In: Schmidtke A, Bille-Brahe U, Leo D, Kerkhof A, editors(s). Suicidal Behaviour in Europe: Results from the WHO/EURO Multicentre Study on Suicidal Behaviour. Göttingen, Germany: Hogrefe & Huber Publishers, 2004:15-28.
Schultz 1995
    1. Schultz KF. Subverting randomization in controlled trials. Journal of the American Medical Association 1995;274:1456-8. - PubMed
Schünemann 2008a
    1. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Presenting results and 'summary of findings’ tables. In: Higgins JPT, Green S, editors(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester, UK: John Wiley & Sons, 2008.
Schünemann 2008b
    1. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Interpreting results and drawing conclusions. In: Higgins JPT, Green S, editors(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester, UK: John Wiley & Sons, 2008.
Scoliers 2009
    1. Scoliers G, Portzky G, Madge N, Hewitt A, Hawton K, Wilde EJ, et al. Reasons for adolescent deliberate self-harm: A cry of pain and/or a cry for help? Findings from the child and adolescent self-harm in Europe (CASE) study. Social Psychiatry and Psychiatric Epidemiology 2009;44:601-7. - PubMed
Sinclair 2011
    1. Sinclair JMA, Gray A, Rivero-Arias O, Saunders KEA, Hawton K. Healthcare and social services resource use and costs of self-harm patients. Social Psychiatry and Psychiatric Epidemiology 2011;46:263-71. - PubMed
Smith 2005
    1. Smith BD. Self-mutilation and pharmacotherapy. Psychiatry 2005;2:28-37. - PMC - PubMed
Stoffers 2010
    1. Stoffers J, Völlm BA, Rücker G, Timmer A, Huband N, Lieb K. Pharmacological interventions for borderline personality disorder. Cochrane Database of Systematic Reviews 2010, Issue 6. Art. No: CD005653. [DOI: 10.1002/14651858.CD005653.pub2] - DOI - PMC - PubMed
Sublette 2006
    1. Sublette ME, Hibbeln JR, Galfalvy H, Oquendo MA, Mann JJ. Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. American Journal of Psychiatry 2006;163(6):1100-2. - PubMed
Tanskanen 2001
    1. Tanskanen A, Hibbeln JR, Hintikka J, Haatainen K, Honkalampi K, Viinamäki H. Fish consumption, depression, and suicidality in a general population. Archives of General Psychiatry 2001;58:512-13. - PubMed
Tarrier 2008
    1. Tarrier N, Taylor K, Gooding P. Cognitive-behavioral interventions to reduce suicide behavior: A systematic review and meta-analysis. Behavior Modification 2008;32:77-108. - PubMed
Tondo 1997
    1. Tondo L, Jamison KR, Baldessarini RJ. Effect of lithium maintenance on suicidal behavior in major mood disorders. Annals of the New York Academy of Science 1997;836:339-51. - PubMed
Tondo 2000
    1. Tondo L, Baldessarini RJ. Reduced suicide risk during lithium maintenance treatment. Journal of Clinical Psychiatry 2000;61:s97-104. - PubMed
Tondo 2001
    1. Tondo L, Hennen J, Baldessarini RJ. Lower suicide risk with long-term lithium treatment in major affective illness: A meta-analysis. Acta Psychiatrica Scandinavica 2001;104:163-72. - PubMed
Torgerson 2004
    1. Torgerson D. The use of Zelen's design in randomised trials. British Journal of Obstetrics and Gynaecology: An International Journal of Obstetrics and Gynaecology 2004;111:2. - PubMed
Townsend 2001
    1. Townsend E, Hawton K, Altman D, Arensman E, Gunnell D, Hazell P, et al. The efficacy of problem-solving treatments after deliberate self-harm: Meta-analysis of randomized controlled trials with respect to depression, hopelessness and improvement in problems. Psychological Medicine 2001;31:979-88. - PubMed
Tyrer 2012
    1. Tyrer P. Why benzodiazepines are not going away. Commentary on benzodiazepines for anxiety disorders. Advances in Psychiatic Treatment 2012;18:259-62.
van der Sande 1997
    1. Sande R, Buskens E, Allart E, Graaf Y, Engeland H. Psychosocial intervention following suicide attempt: A systematic review of treatment interventions. Acta Psychiatrica Scandinavica 1997;96:43-50. - PubMed
van Heeringen 2014
    1. Heeringen K, Mann JJ. The neurobiology of suicide. The Lancet Psychiatry 2014;1:63-72. - PubMed
Värnik 2004
    1. Värnik A, Küpersepp O, Marandi T, Palo E. Suicidal behaviour in Estonia. In: Schmidtke A, Bille-Brahe U, Leo D, Kerkhof A, editors(s). Suicidal behaviour in Europe: Results from the WHO/EURO Multicentre Study on Suicidal Behaviour. Göttingen, Germany: Hogrefe & Huber Publishers, 2004:195-200.
Verkes 2000
    1. Verkes RJ, Cowen PJ. Pharmacotherapy of suicidal ideation and behaviour. In: Hawton K, Heeringen K, editors(s). The International Handbook of Suicide and Attempted Suicide. Chichester, UK: John Wiley and Sons, 2000.
World Health Organization 2014
    1. World Health Organization. Preventing suicide: A global imperative. Geneva, Switzerland: World Health Organization, 2014.
Zahl 2004
    1. Zahl D, Hawton K. Repetition of deliberate self-harm and subsequent suicide risk: long-term follow-up study in 11,583 patients. British Journal of Psychiatry 2004;185:70-5. - PubMed
Zigmond 1983
    1. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica 1983;67:361-70. - PubMed

References to other published versions of this review

Hawton 1998
    1. Hawton K, Arensman E, Townsend E, Bremner S, Feldman E, Goldney R, et al. Deliberate self harm: Systematic review of efficacy of psychosocial and pharmacological treatments in preventing repetition. British Medical Journal 1998;317:441-7. - PMC - PubMed
Hawton 1999
    1. Hawton K, Townsend E, Arensman E, Gunnell D, Hazell P, House A, et al. Psychosocial and pharmacological treatments for deliberate self harm. Cochrane Database of Systematic Reviews 1999, Issue 4. Art. No: CD001764. [DOI: 10.1002/14651858.CD001764] - DOI - PMC - PubMed
NICE 2011
    1. National Institute for Health and Clinical Excellence. Self-harm: Longer-term Management. NICE clinical guideline 133. London: National Institute for Health and Clinical Excellence, 2011. - PubMed

Publication types